T LANE M FOLSE

Allopathic & Osteopathic Physicians|Internal Medicine BAKER, LA NPI 1750331997

General Payments — all program years on this page

$3,827.44

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 238
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $412.33 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $412.3320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $621.5542
2019 $571.5540
2020 $263.6717
2021 $600.8336
2022 $875.4553
2023 $482.0630
2024 $412.3320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086130458 Bayer Healthcare Pharmaceuticals Inc. $24.62 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086198176 Bayer Healthcare Pharmaceuticals Inc. $20.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1087889967 BETA BIONICS, INC. $123.55 12/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1097465206 Novo Nordisk Inc $16.50 03/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118138272 Boehringer Ingelheim Pharmaceuticals, Inc. $15.51 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135401029 Lilly USA, LLC $14.28 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135423797 Lilly USA, LLC $14.28 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135432177 Lilly USA, LLC $13.00 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135432179 Lilly USA, LLC $9.34 08/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135435495 Lilly USA, LLC $14.70 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135436629 Lilly USA, LLC $14.13 09/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135436631 Lilly USA, LLC $14.28 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135436633 Lilly USA, LLC $15.58 04/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135454569 Lilly USA, LLC $11.83 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135454571 Lilly USA, LLC $3.52 08/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135459540 Lilly USA, LLC $13.00 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135471699 Lilly USA, LLC $14.00 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137549232 Takeda Pharmaceuticals U.S.A., Inc. $13.36 12/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144615123 Xeris Pharmaceuticals, Inc. $19.62 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153339539 Dexcom, Inc. $27.12 07/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.